ANL 29.15 Increased By ▲ 0.63 (2.21%)
ASC 16.50 Decreased By ▼ -0.18 (-1.08%)
ASL 25.15 Increased By ▲ 1.39 (5.85%)
AVN 99.18 Increased By ▲ 4.94 (5.24%)
BOP 9.51 Increased By ▲ 0.04 (0.42%)
BYCO 9.36 Decreased By ▼ -0.20 (-2.09%)
DGKC 112.10 Increased By ▲ 1.60 (1.45%)
EPCL 47.55 Increased By ▲ 0.10 (0.21%)
FCCL 21.50 Increased By ▲ 0.22 (1.03%)
FFBL 28.84 Increased By ▲ 0.87 (3.11%)
FFL 19.23 Decreased By ▼ -0.04 (-0.21%)
HASCOL 14.08 Decreased By ▼ -0.23 (-1.61%)
HUBC 86.75 Increased By ▲ 0.75 (0.87%)
HUMNL 7.25 Decreased By ▼ -0.05 (-0.68%)
JSCL 32.39 Increased By ▲ 0.92 (2.92%)
KAPCO 40.81 Increased By ▲ 0.08 (0.2%)
KEL 4.18 Increased By ▲ 0.07 (1.7%)
LOTCHEM 15.99 Decreased By ▼ -0.21 (-1.3%)
MLCF 43.90 Increased By ▲ 0.89 (2.07%)
PAEL 40.06 Increased By ▲ 0.20 (0.5%)
PIBTL 13.04 Increased By ▲ 0.13 (1.01%)
POWER 11.65 Increased By ▲ 0.25 (2.19%)
PPL 93.72 Increased By ▲ 0.42 (0.45%)
PRL 23.80 No Change ▼ 0.00 (0%)
PTC 9.37 Increased By ▲ 0.07 (0.75%)
SILK 1.22 Increased By ▲ 0.02 (1.67%)
SNGP 44.60 Increased By ▲ 0.27 (0.61%)
TRG 114.93 Increased By ▲ 6.45 (5.95%)
UNITY 33.68 Increased By ▲ 0.53 (1.6%)
WTL 1.09 Decreased By ▼ -0.03 (-2.68%)
BR100 4,947 Increased By ▲ 37.17 (0.76%)
BR30 25,638 Increased By ▲ 275.5 (1.09%)
KSE100 46,484 Increased By ▲ 196.24 (0.42%)
KSE30 19,363 Increased By ▲ 103.69 (0.54%)
World

Russia's Sputnik V coronavirus vaccine is 95 percent effective

  • The first international deliveries of the vaccine will be made to customers in January 2021.
24 Nov 2020

Russia has said that its Sputnik V COVID-19 vaccine, which is the world’s first registered vaccine against coronavirus based on a well-studied platform of human adenoviral vectors, is 95 % effective.

The calculation was based on the analysis of data on volunteers who received both the first and second doses of the Sputnik V on November 23.

The preliminary data on volunteers on the 42nd day after the first dose (equivalent to 21 days after the second dose) indicated the efficacy rate of the vaccine is above 95%.

As part of the ongoing clinical trials, on November 24, 22,000 volunteers were vaccinated with the first dose and more than 19,000 volunteers were given the first and second doses at 29 medical centers in Russia. "There were no unexpected adverse events during the trials. Monitoring of the participants is ongoing," Sputnik V said.

“The data demonstrating high efficacy of the Sputnik V vaccine give us hope that we will soon obtain the most important tool in the fight against the pandemic of the novel coronavirus infection,” Minister of Health Mikhail Murashko said.

Meanwhile, Russia has announced that the first international deliveries of the vaccine will be made to customers in January 2021. The cost of one dose of the Sputnik V vaccine for the external market will be less than $10. Whereas, it will be free of charge for Russian citizens.